| Product Code: ETC10075732 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Hematology Oncology Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Hematology Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Hematology Oncology Market - Industry Life Cycle |
3.4 Vietnam Hematology Oncology Market - Porter's Five Forces |
3.5 Vietnam Hematology Oncology Market Revenues & Volume Share, By Hematology Product, 2021 & 2031F |
3.6 Vietnam Hematology Oncology Market Revenues & Volume Share, By Oncology Drug Class Type, 2021 & 2031F |
3.7 Vietnam Hematology Oncology Market Revenues & Volume Share, By Oncology Indication, 2021 & 2031F |
3.8 Vietnam Hematology Oncology Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.9 Vietnam Hematology Oncology Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Vietnam Hematology Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Vietnam |
4.2.2 Growing awareness about early detection and treatment of hematologic and oncologic diseases |
4.2.3 Technological advancements in hematology oncology treatments |
4.3 Market Restraints |
4.3.1 High cost of hematology oncology treatments |
4.3.2 Limited access to specialized healthcare facilities in remote areas of Vietnam |
4.3.3 Lack of skilled healthcare professionals in the field of hematology oncology |
5 Vietnam Hematology Oncology Market Trends |
6 Vietnam Hematology Oncology Market, By Types |
6.1 Vietnam Hematology Oncology Market, By Hematology Product |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Hematology Oncology Market Revenues & Volume, By Hematology Product, 2021- 2031F |
6.1.3 Vietnam Hematology Oncology Market Revenues & Volume, By Hematology Analyzers, 2021- 2031F |
6.1.4 Vietnam Hematology Oncology Market Revenues & Volume, By Hematology Reagents, 2021- 2031F |
6.1.5 Vietnam Hematology Oncology Market Revenues & Volume, By Flow Cytometers, 2021- 2031F |
6.1.6 Vietnam Hematology Oncology Market Revenues & Volume, By Hematology Cell Counters, 2021- 2031F |
6.1.7 Vietnam Hematology Oncology Market Revenues & Volume, By Slide Strainers, 2021- 2031F |
6.1.8 Vietnam Hematology Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Hematology Oncology Market, By Oncology Drug Class Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Hematology Oncology Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.2.3 Vietnam Hematology Oncology Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.2.4 Vietnam Hematology Oncology Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.2.5 Vietnam Hematology Oncology Market Revenues & Volume, By Hormonal Therapy, 2021- 2031F |
6.3 Vietnam Hematology Oncology Market, By Oncology Indication |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Hematology Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.3 Vietnam Hematology Oncology Market Revenues & Volume, By Stomach Cancer, 2021- 2031F |
6.3.4 Vietnam Hematology Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 Vietnam Hematology Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.6 Vietnam Hematology Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.4 Vietnam Hematology Oncology Market, By Applications |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Hematology Oncology Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.4.3 Vietnam Hematology Oncology Market Revenues & Volume, By Cancer, 2021- 2031F |
6.4.4 Vietnam Hematology Oncology Market Revenues & Volume, By Cardiovascular Disorders, 2021- 2031F |
6.4.5 Vietnam Hematology Oncology Market Revenues & Volume, By Blood Screening, 2021- 2031F |
6.4.6 Vietnam Hematology Oncology Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.4.7 Vietnam Hematology Oncology Market Revenues & Volume, By HIV, 2021- 2031F |
6.5 Vietnam Hematology Oncology Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Vietnam Hematology Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Vietnam Hematology Oncology Market Revenues & Volume, By Clinical Testing Institutes, 2021- 2031F |
6.5.4 Vietnam Hematology Oncology Market Revenues & Volume, By Patient Self-Testing, 2021- 2031F |
6.5.5 Vietnam Hematology Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Hematology Oncology Market Import-Export Trade Statistics |
7.1 Vietnam Hematology Oncology Market Export to Major Countries |
7.2 Vietnam Hematology Oncology Market Imports from Major Countries |
8 Vietnam Hematology Oncology Market Key Performance Indicators |
8.1 Number of patients receiving hematology oncology treatments |
8.2 Adoption rate of new hematology oncology technologies |
8.3 Number of healthcare facilities offering specialized hematology oncology services |
9 Vietnam Hematology Oncology Market - Opportunity Assessment |
9.1 Vietnam Hematology Oncology Market Opportunity Assessment, By Hematology Product, 2021 & 2031F |
9.2 Vietnam Hematology Oncology Market Opportunity Assessment, By Oncology Drug Class Type, 2021 & 2031F |
9.3 Vietnam Hematology Oncology Market Opportunity Assessment, By Oncology Indication, 2021 & 2031F |
9.4 Vietnam Hematology Oncology Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.5 Vietnam Hematology Oncology Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Vietnam Hematology Oncology Market - Competitive Landscape |
10.1 Vietnam Hematology Oncology Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Hematology Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here